Register
Login:
Share:
Email Facebook Twitter

PXS Share Chat - RSS Feed

Provexis Share Chat (PXS)



Share Price: 0.70Bid: 0.65Ask: 0.75Change: 0.015 (+2.19%)Riser - Provexis
Spread: 0.10Spread as %: 15.38%Open: 0.70High: 0.70Low: 0.70Yesterday’s Close: 0.685


Share Discussion for Provexis (PXS)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


gaj1
Posts: 449
Observation
Opinion:Hold
Price:0.83
View Thread (6)
Blizzard 17.36 Saturday post
27 Jul '14
Exactly my thoughts. Gd post mate.

People need to do some simple calcs on what the potential return to dsm and then pxs could be on x amount of daily global users. A fraction of the global population could well return very nicely to pxs, and pretty much most will go straight to bottom line profit!

I will wait this out, as I am positive it will do good long term. All thought I could use some money now :-)
 
jonesy229
Posts: 261
Off Topic
Opinion:No Opinion
Price:0.83
sirco
27 Jul '14
sorry i mean health bay .co
jonesy229
Posts: 261
Off Topic
Opinion:No Opinion
Price:0.83
sirco
27 Jul '14
i have found some where i can get it now i have been using circlees but prefer sirco i used to get it from amazon
but since they stopped cant find it anywhere due to living in north wales no waitrose or sainsburyes i got it from healthspan, co simlaur to amazon may be of interest to anybody with same problem
gixer
Posts: 623
Off Topic
Opinion:No Opinion
Price:0.83
View Thread (6)
RE: One to watch
27 Jul '14
I have a feeling that XSurge may have some connection to AssuriTEA® Sport but may include other ingredients.

They seem to be keeping ingredients pretty quiet. Maybe until the patent is published.

http://www.kemin.com/products/assuritea
tooldoctor
Posts: 1,684
Observation
Opinion:No Opinion
Price:0.83
moe
27 Jul '14
is MORE of course, sorry folks.
Paludina
Posts: 51
Observation
Opinion:No Opinion
Price:0.83
View Thread (6)
RE: One to watch
27 Jul '14
In September 2008, DSM inked a deal with Capsugel for the commercial manufacture of naproxcinod oral capsules. “The latest positive results observed in the 111 and 303 studies support our confidence in naproxcinod’s blockbuster potential,” states Staffan Strömberg, vp of technical development and operations at NicOx. “We are therefore very pleased to have signed these contracts with global leaders in high-capacity API and capsule production.”
From
http://www.genengnews.com/gen-news-highlights/dsm-to-lend-manufacturing-support-for-nicox-39-anticipated-osteoarthriti/46474652/?kwrd=Capsugel
Blizzard
Posts: 84
Question
Opinion:No Opinion
Price:0.83
View Thread (6)
RE: One to watch
27 Jul '14
Thanks gixer.

Also found this which references innovative new sports dosage forms.

http://capsugel.com/en/news-events/webinars/

The Co produces 200 billion capsules p.a. so hopefully a connection to FF.
gixer
Posts: 623
Off Topic
Opinion:No Opinion
Price:0.83
View Thread (6)
RE: One to watch
26 Jul '14
gixer
Posts: 623
Off Topic
Opinion:No Opinion
Price:0.83
View Thread (6)
RE: One to watch
26 Jul '14
Nice find.

Only had a quick look so far and cant find anything to link it to ff
Kemin on the other hand does have a connection to DSM
http://www.sportsnutrition-event.com/kemin-xsurge/
Kemin Human Nutrition and Health division develops high quality science based ingredients with healthful benefits for the dietary supplement and functional food and beverage markets

http://www.dsm.com/markets/foodandbeverages/en_US/products/carotenoids/flora-glo-lutein.html

FloraGLO® lutein is the most clinically researched lutein brand worldwide - manufactured by Kemin Health and formulated by DSM as part of an exclusive strategic alliance.

Will check it out later and see if I can find anything.



Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs

Sign up for Live Prices
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.